MPM ASSET MANAGEMENT LLC - Q4 2018 holdings

$118 Million is the total value of MPM ASSET MANAGEMENT LLC's 6 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .

 Value Shares↓ Weighting
RYTM  Rhythm Pharmaceuticals, Inc.$82,653,000
-7.9%
3,074,8930.0%69.94%
+15.2%
CHMA  Chiasma, Inc.$17,840,000
-13.6%
5,736,2960.0%15.10%
+8.0%
SNDX  Syndax Pharmaceuticals, Inc.$9,651,000
-44.9%
2,168,6910.0%8.17%
-31.2%
CNAT  Conatus Pharmaceuticals, Inc.$4,264,000
-70.2%
2,464,8070.0%3.61%
-62.7%
PRTO  Proteon Therapeutics, Inc.$2,232,000
+16.4%
983,3810.0%1.89%
+45.4%
PETX  Aratana Therapeutics Inc.$1,533,000
+5.0%
250,0000.0%1.30%
+31.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Chiasma, Inc.24Q2 202119.8%
Aratana Therapeutics, Inc.24Q1 201926.8%
Conatus Pharmaceuticals, Inc.23Q1 20199.7%
Rhythm Pharmaceuticals, Inc.19Q2 202269.9%
Harpoon Therapeutics, Inc.19Q3 202331.9%
Syndax Pharmaceuticals, Inc.19Q3 202014.5%
Radius Health, Inc.17Q2 201876.4%
TCR2 Therapeutics, Inc.17Q1 202329.1%
Repare Therapeutics, Inc.17Q2 202427.7%
Proteon Therapeutics, Inc.17Q4 20183.0%

View MPM ASSET MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-21
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR/A2023-09-07
13F-HR2023-08-14
42023-06-05
42023-05-24
13F-HR2023-05-12

View MPM ASSET MANAGEMENT LLC's complete filings history.

Compare quarters

Export MPM ASSET MANAGEMENT LLC's holdings